DK2323642T3 - Anvendelse af EDTA+tromethamin eller af fotoforstærkere i forbindelse med riboflavin til hornhindetværbinding ved behandling af keratoconus eller af andre ektatiske hornhindelidelser - Google Patents

Anvendelse af EDTA+tromethamin eller af fotoforstærkere i forbindelse med riboflavin til hornhindetværbinding ved behandling af keratoconus eller af andre ektatiske hornhindelidelser

Info

Publication number
DK2323642T3
DK2323642T3 DK09748494.3T DK09748494T DK2323642T3 DK 2323642 T3 DK2323642 T3 DK 2323642T3 DK 09748494 T DK09748494 T DK 09748494T DK 2323642 T3 DK2323642 T3 DK 2323642T3
Authority
DK
Denmark
Prior art keywords
corneal
keratoconus
tromethamine
riboflavin
enhancers
Prior art date
Application number
DK09748494.3T
Other languages
English (en)
Inventor
Marcello Stagni
Edoardo Stagni
Massimo Filippello
Giovanni Cavallo
Eugenio Sodo
Original Assignee
Sooft Italia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40679354&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2323642(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sooft Italia Spa filed Critical Sooft Italia Spa
Application granted granted Critical
Publication of DK2323642T3 publication Critical patent/DK2323642T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/49—Cinchonan derivatives, e.g. quinine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
DK09748494.3T 2008-08-28 2009-08-27 Anvendelse af EDTA+tromethamin eller af fotoforstærkere i forbindelse med riboflavin til hornhindetværbinding ved behandling af keratoconus eller af andre ektatiske hornhindelidelser DK2323642T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITRM2008A000472A IT1393402B1 (it) 2008-08-28 2008-08-28 Uso di enhancer eventualmente con riboflavina, nonche' relative composizioni oftalmiche per cross-linking corneale del cheratocono o di altre patologie ectasiche corneali
PCT/IT2009/000392 WO2010023705A1 (en) 2008-08-28 2009-08-27 Use of enhancers, possibly associated to riboflavin, as well as corresponding ophthalmic compositions for corneal cross-linking in the treatment of the keratoconus or of other corneal ectasic disorders

Publications (1)

Publication Number Publication Date
DK2323642T3 true DK2323642T3 (da) 2014-05-05

Family

ID=40679354

Family Applications (1)

Application Number Title Priority Date Filing Date
DK09748494.3T DK2323642T3 (da) 2008-08-28 2009-08-27 Anvendelse af EDTA+tromethamin eller af fotoforstærkere i forbindelse med riboflavin til hornhindetværbinding ved behandling af keratoconus eller af andre ektatiske hornhindelidelser

Country Status (18)

Country Link
US (1) US20110152219A1 (da)
EP (1) EP2323642B1 (da)
JP (1) JP2012500844A (da)
KR (1) KR20110046567A (da)
CN (1) CN102164592B (da)
AU (1) AU2009286285B2 (da)
BR (1) BRPI0910368B8 (da)
CL (1) CL2011000378A1 (da)
DK (1) DK2323642T3 (da)
EA (2) EA023607B1 (da)
ES (1) ES2460578T3 (da)
IL (1) IL211448A (da)
IT (1) IT1393402B1 (da)
MX (2) MX358176B (da)
PE (1) PE20110287A1 (da)
PL (1) PL2323642T3 (da)
PT (1) PT2323642E (da)
WO (1) WO2010023705A1 (da)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8545487B2 (en) 2007-12-05 2013-10-01 Avedro Inc. Eye therapy system
WO2010039854A1 (en) 2008-09-30 2010-04-08 Neal Marshall Eye therapy system
US8574277B2 (en) 2009-10-21 2013-11-05 Avedro Inc. Eye therapy
WO2011116306A2 (en) 2010-03-19 2011-09-22 Avedro, Inc. Systems and methods for applying and monitoring eye therapy
US20110280763A1 (en) * 2010-05-17 2011-11-17 Abbott Medical Optics Inc. Light-activated disinfection system
IT1400982B1 (it) 2010-07-05 2013-07-05 Pinelli Collirio osmotico trans-epiteliale per la cura del cheratocono.
US9622911B2 (en) 2010-09-30 2017-04-18 Cxl Ophthalmics, Llc Ophthalmic treatment device, system, and method of use
US20130310732A1 (en) * 2011-01-12 2013-11-21 Sooft Italia Spa Corneal delivery of cross-linking agents by iontophoresis for the treatment of keratoconus and related ophthalmic compositions
MX347934B (es) 2011-01-12 2017-05-18 Sooft Italia Spa Dispositivo y método para el suministro de riboflavina en la córnea, mediante iontoforesis, para el tratamiento de queratocono.
WO2012158991A2 (en) * 2011-05-18 2012-11-22 Avedro, Inc. Controlled application of cross-linking agent
WO2012162529A1 (en) 2011-05-24 2012-11-29 Avedro, Inc. Systems and methods for reshaping an eye feature
JP6122845B2 (ja) 2011-06-02 2017-04-26 アヴェドロ・インコーポレーテッドＡｖｅｄｒｏ，Ｉｎｃ． 時間ベースの光活性剤の送達又は光活性マーカの存在をモニターするシステム及び方法
ITRM20110560A1 (it) * 2011-10-25 2013-04-26 Sooft Italia Spa Migliorata composizione di cross-linking per il trattamento del cheratocono mediante iontoforesi
RU2481809C1 (ru) * 2011-12-21 2013-05-20 Федеральное государственное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова Федерального агентства по высокотехнологичной медицинской помощи" Способ лечения кератэктазии после лазик
WO2013148895A1 (en) 2012-03-29 2013-10-03 Cxl Ophthalmics, Llc Ocular cross-linking system and method for sealing corneal wounds
EP2830627B1 (en) 2012-03-29 2024-05-01 Epion Therapeutics, Inc. Ocular treatment solutions, delivery devices and delivery augmentation methods
US9566301B2 (en) 2012-03-29 2017-02-14 Cxl Ophthalmics, Llc Compositions and methods for treating or preventing diseases associated with oxidative stress
RU2487691C1 (ru) * 2012-04-12 2013-07-20 Федеральное государственное бюджетное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова" Министерства здравоохранения и социального развития Российской Федерации Способ лечения кератоконуса
EP2872081B1 (en) 2012-07-16 2022-06-08 Avedro, Inc. Systems for corneal cross-linking with pulsed light
PT2948113T (pt) * 2013-01-28 2018-05-22 Novartis Ag Aparelho para formação corneal de ligações cruzadas
WO2014189849A1 (en) * 2013-05-19 2014-11-27 Avedro, Inc. Systems, methods, and compositions for cross-linking
US9498114B2 (en) 2013-06-18 2016-11-22 Avedro, Inc. Systems and methods for determining biomechanical properties of the eye for applying treatment
WO2014205145A1 (en) 2013-06-18 2014-12-24 Avedro, Inc. Systems and methods for determining biomechanical properties of the eye for applying treatment
RU2542799C1 (ru) * 2013-10-29 2015-02-27 Игорь Борисович Медведев Способ лечения кератоконуса роговицы
US9931199B2 (en) * 2014-05-05 2018-04-03 Roberto Gustavo ALBERTAZZI Methods and apparatus for treating keratoconus
US9427355B1 (en) * 2014-05-12 2016-08-30 Gholam A. Peyman Corneal transplantation with a cross-linked cornea
US10709546B2 (en) 2014-05-12 2020-07-14 Gholam A. Peyman Intracorneal lens implantation with a cross-linked cornea
US10314690B1 (en) 2014-05-12 2019-06-11 Gholam A. Peyman Method of corneal transplantation or corneal inlay implantation with cross-linking
US10881503B2 (en) 2014-05-12 2021-01-05 Gholam A. Peyman Method of corneal transplantation or corneal inlay implantation with cross-linking
US9744029B1 (en) 2014-05-12 2017-08-29 Gholam A. Peyman Method of preventing capsular opacification and fibrosis utilizing an accommodative intraocular lens implant
US9937033B1 (en) 2014-05-12 2018-04-10 Gholam A. Peyman Corneal lenslet implantation with a cross-linked cornea
US10925889B2 (en) 2014-05-12 2021-02-23 Gholam A. Peyman Method of treating, reducing, or alleviating a medical condition in a patient
US11045352B2 (en) 2014-05-12 2021-06-29 Gholam A. Peyman Methods for treatment of dry eye and other acute or chronic inflammatory processes
US11565023B2 (en) 2014-05-12 2023-01-31 Gholam A. Peyman Method of corneal transplantation or corneal inlay implantation with cross-linking
US10206569B1 (en) 2014-05-12 2019-02-19 Gholam A. Peyman Corneal intraocular pressure sensor and a surgical method using the same
US11648261B2 (en) 2014-05-12 2023-05-16 Gholam A. Peyman Method of treating, reducing, or alleviating a medical condition in a patient
US10583221B2 (en) 2014-05-12 2020-03-10 Gholam A. Peyman Method of corneal transplantation or corneal inlay implantation with cross-linking
US11666777B2 (en) 2014-05-12 2023-06-06 Gholam A. Peyman Photodynamic therapy technique for preventing damage to the fovea of the eye or another body portion of a patient
US10278920B1 (en) 2014-05-12 2019-05-07 Gholam A. Peyman Drug delivery implant and a method using the same
US11338059B2 (en) 2014-05-12 2022-05-24 Gholam A. Peyman Method of corneal and scleral inlay crosslinking and preservation
US10195081B1 (en) 2014-05-12 2019-02-05 Gholam A. Peyman Method of prevention of capsular opacification and fibrosis after cataract extraction and/or prevention of fibrosis around a shunt or stent after glaucoma surgery
US11259914B2 (en) 2014-05-12 2022-03-01 Gholam A. Peyman Molding or 3-D printing of a synthetic refractive corneal lenslet
JP6644799B2 (ja) 2014-10-27 2020-02-12 アヴェドロ・インコーポレーテッドＡｖｅｄｒｏ，Ｉｎｃ． 眼の架橋処置のためのシステム及び方法
WO2016077747A1 (en) 2014-11-13 2016-05-19 Avedro, Inc. Multipass virtually imaged phased array etalon
WO2016172695A1 (en) 2015-04-24 2016-10-27 Avedro, Inc. Systems and methods for photoactivating a photosensitizer applied to an eye
HUE040373T2 (hu) 2015-04-29 2019-03-28 Sooft Italia S P A Kollagén-rostok javított térhálósító szerei cornealis ectasia kezelésében való alkalmazásra
US10028657B2 (en) 2015-05-22 2018-07-24 Avedro, Inc. Systems and methods for monitoring cross-linking activity for corneal treatments
EP3324973B1 (en) 2015-07-21 2020-06-03 Avedro, Inc. Treament of an eye with a photosensitizer
CN105256059B (zh) * 2015-11-20 2019-01-18 山东省眼科研究所 Tuba3d基因在制备圆锥角膜诊断制品中的应用
ITUB20160237A1 (it) * 2016-01-26 2017-07-26 Vision Engineering Italy Soc A Responsabilita Limitata Apparato di controllo del dosaggio di un agente cromoforo in un tessuto corneale e procedimento per dosare un agente cromoforo in un tessuto corneale
EP3442481B1 (en) 2016-04-13 2023-06-28 Avedro, Inc. Systems for delivering drugs to an eye
EP3585393A4 (en) * 2017-02-21 2020-12-30 Avedro, Inc. FORMULATIONS FOR EYE TREATMENTS
EP3761928A1 (en) 2018-03-08 2021-01-13 Avedro, Inc. Micro-devices for treatment of an eye
CN118217090A (zh) 2018-10-09 2024-06-21 艾维德洛公司 用于角膜交联治疗的光活化系统及方法
US11707518B2 (en) 2019-04-28 2023-07-25 Gholam A. Peyman Method of treating, reducing, or alleviating a medical condition in a patient
JP2022544110A (ja) 2019-08-06 2022-10-17 アヴェドロ・インコーポレーテッド 角膜の架橋治療のための光活性化システム及び方法
CN110314034B (zh) * 2019-08-08 2021-12-03 南京市第一医院 一种可实现个性治疗的角膜交联装置
US11458220B2 (en) 2020-11-12 2022-10-04 Singletto Inc. Microbial disinfection for personal protection equipment
CN115177729B (zh) * 2022-08-03 2023-09-26 山东第一医科大学附属眼科研究所(山东省眼科研究所、山东第一医科大学附属青岛眼科医院) 肾上腺素受体激动剂在制备圆锥角膜交联促渗剂中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050002867A1 (en) * 1997-10-01 2005-01-06 Novadel Pharma Inc. Buccal, polar and non-polar sprays containing propofol
DE69928087D1 (de) 1998-03-09 2005-12-08 Ista Pharmaceuticals Inc Verwendung von glyceraldehyde als hornhaut härtungsmitteln
US6174524B1 (en) 1999-03-26 2001-01-16 Alcon Laboratories, Inc. Gelling ophthalmic compositions containing xanthan gum
ATE489050T1 (de) * 2000-02-11 2010-12-15 Gen Hospital Corp Photochemische gewebeverbindung
EA008496B1 (ru) * 2002-12-20 2007-06-29 Чакшу Рисерч, Инк. Офтальмологический препарат для профилактики и лечения болезненных состояний глаз
ITRM20050443A1 (it) * 2005-08-12 2007-02-13 Opocrin Spa Preparati oftalmici a base di polisaccaridi mucoadesivi con capacita' riepitelizzante della cornea.
EP2464387A4 (en) * 2009-08-12 2013-05-15 Seros Medical Llc DEUTERATED WATER SOLUTION AND RIBOFLAVIN FOR EXTENDED OXYGEN SINGULET LIFETIME IN THE TREATMENT OF OCULAR TISSUE AND METHOD OF USE

Also Published As

Publication number Publication date
MX358176B (es) 2018-08-08
AU2009286285A1 (en) 2010-03-04
AU2009286285B2 (en) 2015-03-26
US20110152219A1 (en) 2011-06-23
JP2012500844A (ja) 2012-01-12
MX2011002234A (es) 2011-04-05
CN102164592A (zh) 2011-08-24
CN102164592B (zh) 2015-09-23
BRPI0910368B8 (pt) 2021-05-25
EP2323642A1 (en) 2011-05-25
KR20110046567A (ko) 2011-05-04
ITRM20080472A1 (it) 2010-02-28
EA022055B1 (ru) 2015-10-30
EA201300272A1 (ru) 2013-07-30
EA023607B1 (ru) 2016-06-30
BRPI0910368B1 (pt) 2020-01-28
IL211448A0 (en) 2011-05-31
PL2323642T3 (pl) 2014-07-31
PE20110287A1 (es) 2011-05-15
IT1393402B1 (it) 2012-04-20
WO2010023705A1 (en) 2010-03-04
EP2323642B1 (en) 2014-02-19
EA201100393A1 (ru) 2011-10-31
CL2011000378A1 (es) 2011-06-10
PT2323642E (pt) 2014-05-15
BRPI0910368A2 (pt) 2015-10-13
ES2460578T3 (es) 2014-05-13
IL211448A (en) 2016-05-31

Similar Documents

Publication Publication Date Title
DK2323642T3 (da) Anvendelse af EDTA+tromethamin eller af fotoforstærkere i forbindelse med riboflavin til hornhindetværbinding ved behandling af keratoconus eller af andre ektatiske hornhindelidelser
DK2375907T3 (da) Behandling af sygdomme, lidelser eller tilstande i lungerne under anvendelse af placentaceller
DK2483255T3 (da) Oxazinderivater samt deres anvendelse ved behandling af neurologiske lidelser
DK2686434T3 (da) Fremgangsmåde til reduktion af viskositet i saccharificeringsproces
TR201902516T4 (tr) Glukagon-glp-1-gıp üçlü agonist bileşikleri.
DK3108933T3 (da) Indretninger til minimal-invasiv extraokulær levering af radiation til posterior del af øjet
CO7000769A2 (es) Composiciones y métodos para el tratamiento de presbicia, hipermetropía leve, y astigmatismo irregular
DK3714877T3 (da) Fremgangsmåde og sammensætning til behandling af okulær hypertension og glaukom
CO6751293A2 (es) Derivados heterocíclicos novedosos y su uso en e tratamiento de trastornos neurológicos
DK2661263T3 (da) Anvendelse af phytocannabinoid cannabidiol (cbd) i kombination med et standardantiepileptikum (saed) i behandling af epilepsi
DK2545939T3 (da) Tetrahydrobiopterin til behandling af tilstande associeret med forhøjede phenylalaninniveauer
DK2667849T3 (da) Brusende sammensætning i fast form til vaginal anvendelse til behandling af vaginale infektioner
DK2144923T3 (da) Behandlingsfremgangsmåder under anvendelse af glycopegyleret g-csf
DK2838539T3 (da) Østrogenderivater til anvendelse i behandlingen af neurologiske forstyrrelser
DK2892547T3 (da) Dominant, negativ tnf-alpha-hæmmer til anvendelse i behandling af neurologiske cns-forstyrrelser
DK2200600T3 (da) Neramexan til anvendelse ved behandlingen af subakut tinnitus
CR20110029A (es) Moduladores de diamino-piridina, pirimidina, y piridazina del receptor h4 de histamina
DK3533447T3 (da) Flydende bendamustinsammensætninger til anvendelse i fremgangsmåde til behandling af bendamustin-responsive tilstande hos patienter som kræver reducerede volumener til indgivelse
DK2470202T3 (da) Clostridium-neurotoksiner til anvendelse i behandling af præmatur ejakulation
DK2825181T3 (da) Porøse carbonpartikler til anvendelse i behandling eller forebyggelse af leversygdom
DK2307007T3 (da) Sphingosin-1-phosphat-receptormodulatorer samt deres anvendelse til behandling af muskelinflammation
DK3086784T3 (da) Bicalutamid analoger eller (s)-bicalutamid som exocytose aktiverende forbindelser til brug i behandling af lysosomal lagringssygdom eller glycogenose
DK2830645T3 (da) Neuregulin til anvendelse i behandling af perifær nervelæsion
DK2984184T3 (da) Anvendelse af dnq eller dnq-87 i kombination med en parp1-inhibitor til behandlingen af cancer
DK3283064T3 (da) Derivater til anvendelse i behandling af muskelatrofi